乳腺癌中的转化生长因子-β：过多，过晚。
Transforming growth factor-beta in breast cancer: too much, too late.
作者信息
Barcellos-Hoff Mary Helen, Akhurst Rosemary J
机构信息
New York University Langone School of Medicine, New York, NY 10016, USA.
出版信息
Breast Cancer Res. 2009;11(1):202. doi: 10.1186/bcr2224. Epub 2009 Feb 26.
Abstract
The contribution of transforming growth factor (TGF)beta to breast cancer has been studied from a myriad perspectives since seminal studies more than two decades ago. Although the action of TGFbeta as a canonical tumor suppressor in breast is without a doubt, there is compelling evidence that TGFbeta is frequently subverted in a malignant plexus that drives breast cancer. New knowledge that TGFbeta regulates the DNA damage response, which underlies cancer therapy, reveals another facet of TGFbeta biology that impedes cancer control. Too much TGFbeta, too late in cancer progression is the fundamental motivation for pharmaceutical inhibition.
摘要
自二十多年前的开创性研究以来，人们从无数角度研究了转化生长因子（TGF）β对乳腺癌的作用。尽管TGFβ在乳腺中作为典型的肿瘤抑制因子的作用是毫无疑问的，但有令人信服的证据表明，TGFβ在驱动乳腺癌的恶性网络中经常被颠覆。TGFβ调节DNA损伤反应这一癌症治疗基础的新知识，揭示了TGFβ生物学阻碍癌症控制的另一个方面。在癌症进展过程中TGFβ过多、过晚是药物抑制的根本动机。
相似文献
1
Transforming growth factor-beta in breast cancer: too much, too late.乳腺癌中的转化生长因子-β：过多，过晚。
Breast Cancer Res. 2009;11(1):202. doi: 10.1186/bcr2224. Epub 2009 Feb 26.
2
Tumors as organs: biologically augmenting radiation therapy by inhibiting transforming growth factor β activity in carcinomas.肿瘤作为器官：通过抑制癌组织中转化生长因子β活性来增强放射治疗效果。
Semin Radiat Oncol. 2013 Oct;23(4):242-51. doi: 10.1016/j.semradonc.2013.05.001.
3
The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma.转化生长因子-β（TGFβ）信号传导的故事：一个精致的谜团。
IUBMB Life. 2009 Oct;61(10):929-39. doi: 10.1002/iub.239.
4
TGF-beta signaling and its targeted therapy in gastrointestinal cancers.转化生长因子-β信号传导及其在胃肠道癌症中的靶向治疗
Discov Med. 2018 Sep;26(142):103-112.
5
New rationales for using TGFbeta inhibitors in radiotherapy.放疗中使用转化生长因子β抑制剂的新理论依据。
Int J Radiat Biol. 2007 Nov-Dec;83(11-12):803-11. doi: 10.1080/09553000701711063.
6
TGFβ Signaling in the Tumor Microenvironment.TGFβ 信号在肿瘤微环境中的作用。
Adv Exp Med Biol. 2021;1270:89-105. doi: 10.1007/978-3-030-47189-7_6.
7
Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes.乳腺癌抗雌激素耐药3抑制转化生长因子β/Smad信号传导并与良好的乳腺癌疾病预后相关。
Breast Cancer Res. 2014 Dec 13;16(6):476. doi: 10.1186/s13058-014-0476-9.
8
Roles of TGFbeta in metastasis.转化生长因子β在转移中的作用。
Cell Res. 2009 Jan;19(1):89-102. doi: 10.1038/cr.2008.316.
9
TGF beta inhibition for cancer therapy.转化生长因子β抑制用于癌症治疗。
Curr Cancer Drug Targets. 2006 Nov;6(7):565-78. doi: 10.2174/156800906778742460.
10
Malignant cells, directors of the malignant process: role of transforming growth factor-beta.恶性细胞，恶性过程的主导者：转化生长因子-β的作用
Cancer Metastasis Rev. 2001;20(1-2):133-43. doi: 10.1023/a:1013177011767.
引用本文的文献
1
Apelin/APJ: Another Player in the Cancer Biology Network.阿片肽/血管紧张素II 1型受体相关蛋白：癌症生物学网络中的另一个参与者。
Int J Mol Sci. 2025 Mar 25;26(7):2986. doi: 10.3390/ijms26072986.
2
Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER+ Breast Cancer.孕激素受体信号促进 ER+乳腺癌中癌症相关成纤维细胞介导的肿瘤发生。
Endocrinology. 2024 Jul 26;165(9). doi: 10.1210/endocr/bqae092.
3
Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy.用于联合治疗的耐药性、干细胞样乳腺癌细胞的鉴定及药理学靶向研究
bioRxiv. 2025 Feb 12:2023.11.08.562798. doi: 10.1101/2023.11.08.562798.
4
Clinical assessment of TGFB1 and HP Relative Gene Expression in the Peripheral Blood of Prostate Cancer Patients.前列腺癌患者外周血 TGFB1 和 HP 相对基因表达的临床评估。
Asian Pac J Cancer Prev. 2024 Feb 1;25(2):709-717. doi: 10.31557/APJCP.2024.25.2.709.
5
Effects of cilengitide derivatives on TGF-β1-induced epithelial-to-mesenchymal transition and invasion in gefitinib-resistant non-small cell lung cancer cells.西仑吉肽衍生物对吉非替尼耐药的非小细胞肺癌细胞中转化生长因子-β1诱导的上皮-间质转化和侵袭的影响
Front Pharmacol. 2023 Oct 20;14:1277199. doi: 10.3389/fphar.2023.1277199. eCollection 2023.
6
Shaping the "hot" immunogenic tumor microenvironment by nanoparticles co-delivering oncolytic peptide and TGF-β1 siRNA for boosting checkpoint blockade therapy.通过共递送溶瘤肽和TGF-β1小干扰RNA的纳米颗粒塑造“热”免疫原性肿瘤微环境以增强检查点阻断疗法
Bioeng Transl Med. 2022 Aug 11;8(5):e10392. doi: 10.1002/btm2.10392. eCollection 2023 Sep.
7
The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis.趋化因子单核细胞趋化蛋白-1/CCL2 是乳腺癌转移的促进因子。
Cell Mol Immunol. 2023 Jul;20(7):714-738. doi: 10.1038/s41423-023-01013-0. Epub 2023 May 19.
8
A vicious circle in breast cancer: The interplay between inflammation, reactive oxygen species, and microRNAs.乳腺癌中的恶性循环：炎症、活性氧和微小RNA之间的相互作用
Front Oncol. 2022 Sep 26;12:980694. doi: 10.3389/fonc.2022.980694. eCollection 2022.
9
MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levels.MASTL在癌性和多能干细胞中富集，并影响OCT1/OCT4水平。
iScience. 2022 May 25;25(6):104459. doi: 10.1016/j.isci.2022.104459. eCollection 2022 Jun 17.
10
Down-regulation of HOXB5 inhibits TGF-β-induced migration and invasion in hepatocellular carcinoma cells inactivation of the PI3K/Akt pathway.HOXB5的下调通过使PI3K/Akt通路失活抑制转化生长因子-β诱导的肝癌细胞迁移和侵袭。
RSC Adv. 2018 Dec 11;8(72):41415-41421. doi: 10.1039/c8ra06860g. eCollection 2018 Dec 7.
本文引用的文献
1
17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30.17-β-雌二醇通过G蛋白偶联受体30激活细胞外信号调节激酶，抑制乳腺癌细胞中的转化生长因子-β信号传导及功能。
Mol Pharmacol. 2008 Dec;74(6):1533-43. doi: 10.1124/mol.108.046854. Epub 2008 Sep 3.
2
The epithelial-mesenchymal transition generates cells with properties of stem cells.上皮-间质转化产生具有干细胞特性的细胞。
Cell. 2008 May 16;133(4):704-15. doi: 10.1016/j.cell.2008.03.027.
3
An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments.一种抗转化生长因子β抗体通过对多个细胞区室的协同作用抑制转移。
Cancer Res. 2008 May 15;68(10):3835-43. doi: 10.1158/0008-5472.CAN-08-0215.
4
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4.转化生长因子β通过血管生成素样蛋白4使乳腺肿瘤易于发生肺转移播散。
Cell. 2008 Apr 4;133(1):66-77. doi: 10.1016/j.cell.2008.01.046.
5
Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.转化生长因子-β信号通路基因的一致性表观遗传沉默在乳腺癌发生早期就会出现。
Cancer Res. 2007 Dec 15;67(24):11517-27. doi: 10.1158/0008-5472.CAN-07-1284.
6
TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility.转化生长因子β-信号转导分子：分子特异性与功能灵活性
Nat Rev Mol Cell Biol. 2007 Dec;8(12):970-82. doi: 10.1038/nrm2297.
7
Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition.电离辐射使非恶性人乳腺上皮细胞易于发生转化生长因子β诱导的上皮-间质转化。
Cancer Res. 2007 Sep 15;67(18):8662-70. doi: 10.1158/0008-5472.CAN-07-1294.
8
Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF- b1 haploinsufficiency.在TGF-β1单倍体不足情况下对致癌性K-ras阳性肿瘤的肿瘤诱导和进展的调节
Carcinogenesis. 2007 Dec;28(12):2589-96. doi: 10.1093/carcin/bgm136. Epub 2007 Aug 8.
9
TGFbeta-1 dependent fast stimulation of ATM and p53 phosphorylation following exposure to ionizing radiation does not involve TGFbeta-receptor I signalling.暴露于电离辐射后，转化生长因子β-1（TGFbeta-1）依赖性快速刺激ATM和p53磷酸化不涉及转化生长因子β受体I信号传导。
Radiother Oncol. 2007 Jun;83(3):289-95. doi: 10.1016/j.radonc.2007.05.013. Epub 2007 Jun 8.
10
Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.用中和抗体抑制转化生长因子-β可防止辐射诱导的转移性癌症进展加速。
J Clin Invest. 2007 May;117(5):1305-13. doi: 10.1172/JCI30740. Epub 2007 Apr 5.
Zotero 插件